Bio-Rad Laboratories | BIO - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Abbott USD 4.92B 535M 2025-12
Agilent USD 852M 19M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Bio Techne USD 104.6M 6.16M 2025-12
Bio-Rad Laboratories USD 309.6M 3.3M 2025-09
Bruker USD 528M 46.9M 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Danaher USD 2.87B 342M 2025-12
Exact Sciences USD 266.81M 18.18M 2025-09
General Electric Aerospace USD 8.92B 654M 2025-12
Hologic USD 463.7M 5.1M 2025-12
Illumina USD 400M 49M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Merck USD 3.32B 531M 2025-12
Mettler Toledo International USD 473.97M 33.71M 2025-12
Myriad Genetics USD 61.9M 600K 2025-09
OraSure Technologies USD 22.84M 6.8M 2024-09
Pacific Biosciences Of California USD 26.97M 5.12M 2024-09
Quest Diagnostics USD 1.93B 27M 2025-12
Repligen USD 94.08M 5.79M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Siemens EUR 11.51B 1.82B 2025-12
Standard Biotools USD 10.07M 1.06M 2025-09
Thermo Fisher Scientific USD 7.58B 674M 2025-12
Tosoh JPY 190.27B 3.82B 2025-12
Waters USD 374.94M 47.13M 2025-12